Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs
Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;
10.1016/j.aohep.2024.101582
Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation
Takanori Suzuki; Akihiro Tamori; Kentaro Matsuura; Takako Inoue; Shigeru Kusumoto; Shinya Hagiwara; Haruka Sagi; Atsushi Kaneko; Shuko Murakami; Hayato Kawamra; Kei Fujiwara; Katsumi Aoyagi; Masaru Enomoto; Ritsuzo Kozuka; Hiromi Kataoka; Yasuhito Tanaka;
10.1016/j.aohep.2024.101764
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence
Ciro Celsa; Caterina Stornello; Paolo Giuffrida; Carmelo Marco Giacchetto; Mauro Grova; Gabriele Rancatore; Concetta Pitrone; Vito Di Marco; Calogero Cammà ; Giuseppe Cabibbo;
Ann Hepatol. 2022;27 Supl 1: